Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 496

Patients experiment with prescription drugs to fight aging

Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives.

Over the past two years, more than 200 patients have flocked to see Green after learning that two drugs he prescribes could possibly stave off aging. One 95-year-old was so intent on keeping her appointment that she asked her son to drive her from Maryland after a snowstorm had closed the schools.

Green is among a small but growing number of doctors who prescribe drugs “off-label” for their possible anti-aging effects. Metformin is typically prescribed for diabetes, and prevents organ rejection after a transplant, but doctors can prescribe drugs off-label for other purposes—in this case, for “aging.”

Why You Should Attend Undoing Aging 2019

A look at the upcoming Undoing Aging Conference on March 28-30th, Berlin, Germany and some musings on why you should consider going.

As Undoing Aging 2019 in Berlin approaches, I have been reflecting on the previous year and the things that I am most looking forward to this year. So, today, as a journalist and longevity advocate, I am going to be sharing some of my personal musings and thoughts about this important event with you.

First of all, for those of you unfamiliar with the event, a little explanation is in order. Undoing Aging is an industry conference on March 28–30, Berlin, Germany that is organized by the SENS Research Foundation and the Forever Healthy Foundation.

The event has a firm focus on the science and progress being made in aging research and will see many of the leading experts come together for three days of exciting scientific talks, panels, and discussions. Undoing Aging 2019 is the second conference in this series and is one of the must-go events of the year.

Presents its list of the top 30 Longevity Influencers in Singapore

Presents its list of the top 30 Longevity Influencers in Singapore, whose efforts in science, technology, industry and policy are driving the growth of the Singaporean Longevity Landscape.

Link to the Report: https://www.aginganalytics.com/longevity-in-singapore

Dr Finian Tan Brian Kennedy #DannySoon #GaryKhoo #BussarawanTeerawichitchainan #ChongHockSia #JaniceChia #JeffreyLu #CarlFirth #KanwaljitSoin #ChristianiJeyakumarHenry #ColinStewart #HweePinkTan Kenneth Noonan MD #LimChweeTeck #LokSheeMei #MelisTay #NeoKahYean #NgHuckHui #PaoloRampichini #PaulSi #PennyWan #JudithSwain #VishalDoshi #WallaceToores #WilfBlackburn #YuCai #LimXinhong WanJin Hong Birgit Lane.

Clearing Senescent Cells Prevents T1 Diabetes in Mice

Scientists have shown that the removal of non-dividing senescent cells, which are normally associated with aging, also appears to prevent Type 1 diabetes in diabetic mouse strains.

Clearing senescent beta cells prevents T1 diabetes

Type 1 diabetes (T1D) is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone that allows sugar (glucose) to enter cells in order to create energy, so it is critical to cellular function and life.

Aging Analytics Agency has released a prototype version of its interactive online Longevity Industry Analytics platform and database

This platform was applied for the first time in our newly released Longevity Industry in Singapore report, utilizing data on the companies, investors, research labs and non-profit organizations featured in the report.

Aging Analytics Agency is planning to implement a number of updates, additions and enhancement for this platform in the coming months, including interactive and filterable mindmaps, infographics and network diagrams illustrating connections and interactions within the global Longevity Industry, as well as additional features, to be introduced throughout 2019.

Link to Platform: http://mindmaps.aginganalytics.com/

Samsara is Developing Autophagy Boosting Therapies to Combat Aging

Samsara Therapeutics has completed a seed financing round in collaboration with Apollo Ventures, a venture capital company and biotech incubator that supports longevity research and treatments for age-related diseases.

Samsara Therapeutics, Inc. (“Samsara,”) a platform biotechnology startup engaged in the discovery and development of compounds that address the primary molecular causes of aging, announced today the closing of a seed financing round. The financing was led by Apollo Ventures, a life sciences venture capital firm and company builder working across Europe and North America.

Additionally, on February 19th, 2019 Nature Communications published a peer-reviewed paper, “The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species” authored by Samsara’s scientific team [1]. The paper demonstrates the capability of the Samsara platform to identify novel MoA geroprotective small molecules that extend healthy lifespan across species and which are protective in mammalian models of disease.

Archaeologists found an ‘immortality’ elixir hidden in an ancient tomb

Late last year, archaeologists in China found some very interesting items in an ancient tomb dating back as far as 202 BC, including a bronze vessel that somehow still held liquid. The liquid, which at the time was thought to be some type of wine, has since undergone closer examination that reveals its true purpose.

China’s Xinhua news agency is now reporting that the beverage was actually an “elixir of immortality” that matches descriptions from ancient documents. The substance has been tested and, if scientists are right about it, there’s probably little chance it would do anything to extend someone’s life, and may even usher death in even quicker.

/* */